Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for general anesthesia in frail elderly patients undergoing transurethral plasmakinetic enucleation of the prostate
ChiCTR2500111144Phase 4Not yet recruiting
- Sponsor
- Meishan Municipal People's Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Meishan Municipal People's Hospital. Primary endpoint: Hemodynamic/vital sign fluctuations. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on ChiCTR2500111144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111144.